Surges & Plunges - EVOK, OREX, MRUS, IMGN, AGRX

Evoke Pharma Inc. (EVOK) reported additional data from phase III trial of Gimoti, a metoclopramide nasal spray, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in adult

from RTT - Biotech http://ift.tt/2iCnlsA
via IFTTT